YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YIHCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $577,233 | $2,126,771 | $76,603 | -$587,649 |
| Dep. & Amort. | $395,660 | $391,274 | $377,357 | $259,816 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $89,971 | $45,136 | $0 | $0 |
| Change in WC | -$826,352 | -$1,402,443 | -$565,920 | -$117,523 |
| Other Non-Cash | -$147,094 | $512,474 | $1,811,869 | -$217,154 |
| Operating Cash Flow | $89,418 | $1,673,212 | $1,699,909 | -$662,510 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$968,303 | -$343,718 | -$570,070 | -$356,285 |
| Net Acquisitions | -$12,600 | $0 | $0 | $0 |
| Inv. Purchases | -$2,760,105 | -$1,315,200 | -$290,000 | $0 |
| Inv. Sales/Matur. | $2,763,105 | $3,906,965 | $0 | $0 |
| Other Inv. Act. | $1,066,164 | -$1,693,479 | -$260,091 | -$82,821 |
| Investing Cash Flow | $88,261 | $554,568 | -$1,120,161 | -$439,106 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$463,139 | -$1,339,855 | -$765,724 | $287,277 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14,826 | -$137,044 | -$21,303 | -$99,798 |
| Financing Cash Flow | -$448,313 | -$1,476,899 | -$787,027 | $187,479 |
| Forex Effect | -$2 | -$11 | -$299 | $291 |
| Net Chg. in Cash | -$270,636 | $750,870 | -$207,578 | -$913,846 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,674,413 | $923,543 | $1,131,121 | $2,044,967 |
| End Cash | $1,403,777 | $1,674,413 | $923,543 | $1,131,121 |
| Free Cash Flow | -$1,092,685 | $1,078,134 | $1,129,839 | -$1,018,795 |